Kanglaite Combined With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy for Stage III/IV Non-Small Cell Lung Cancer: A PRISMA-Compliant Meta-Analysis

Objective: Kanglaite(KLT), a type of Chinese medicine preparation, is considered as an adjuvant therapeutic option for malignant cancer treatment. This study aimed to systematically investigate the efficacy and safety of the combination of KLT and epidermal growth factor receptor-tyrosine kinase inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Fanming, Wang, Chaoran, Li, Xiaojiang, Jia, Yingjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473705/
https://www.ncbi.nlm.nih.gov/pubmed/34588988
http://dx.doi.org/10.3389/fphar.2021.739843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473705/
https://www.ncbi.nlm.nih.gov/pubmed/34588988
http://dx.doi.org/10.3389/fphar.2021.739843

Ejemplares similares